J Usher Selected Research

DNA (Deoxyribonucleic Acid)

1/2022

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Usher Research Topics

Disease

2	Alkaptonuria 01/2018 - 01/2018
1	Disease Progression 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 02/2013
1	Osteoporosis 03/2007

Drug/Important Bio-Agent (IBA)

2	nitisinone (Orfadin)FDA Link 01/2018 - 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Amino Acids FDA Link 01/2018
1	DysbindinIBA 02/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2007

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2018